1. Home
  2. LXEO vs LSAK Comparison

LXEO vs LSAK Comparison

Compare LXEO & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

SELL

Current Price

$3.19

Market Cap

348.7M

Sector

N/A

ML Signal

SELL

Logo Lesaka Technologies Inc.

LSAK

Lesaka Technologies Inc.

SELL

Current Price

$3.22

Market Cap

287.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
LXEO
LSAK
Founded
2017
1997
Country
United States
South Africa
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
348.7M
287.3M
IPO Year
2023
2005

Fundamental Metrics

Financial Performance
Metric
LXEO
LSAK
Price
$3.19
$3.22
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $20.67
N/A
AVG Volume (30 Days)
★ 1.1M
175.9K
Earning Date
11-16-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
39.81
★ 102.63
EPS
N/A
★ N/A
Revenue
$654,000.00
★ $721,554,000.00
Revenue This Year
N/A
$11.56
Revenue Next Year
N/A
$14.39
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 9.38
52 Week Low
$2.55
$3.24
52 Week High
$10.99
$5.54

Technical Indicators

Market Signals
Indicator
LXEO
LSAK
Relative Strength Index (RSI) 50.17 25.80
Support Level $2.72 N/A
Resistance Level $3.56 $4.95
Average True Range (ATR) 0.38 0.21
MACD 0.04 -0.06
Stochastic Oscillator 25.62 5.61

Price Performance

Historical Comparison
LXEO
LSAK

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates three reportable segments: Merchant, Consumer, and Enterprise. Merchant, which focuses on both formal and informal sector merchants. Consumer, which focuses on individuals who have historically been excluded from traditional financial services and to whom it offers transactional accounts (banking), insurance, lending (short-term loans), payments solutions and various value-added services; and Enterprise, which comprises large-scale corporate and government organizations, including but not limited to banks, mobile network operators (MNOs) and municipalities, and, through Recharger, landlords utilizing Recharger's prepaid electricity metering solution.

Share on Social Networks: